Cargando…

[(18)F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer

BACKGROUND: The role of image-derived biomarkers in recurrent oligometastatic Prostate Cancer (PCa) is unexplored. This paper aimed to evaluate [(18)F]FMCH PET/CT radiomic analysis in patients with recurrent PCa after primary radical therapy. Specifically, we tested intra-patient lesions similarity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sollini, Martina, Bartoli, Francesco, Cavinato, Lara, Ieva, Francesca, Ragni, Alessandra, Marciano, Andrea, Zanca, Roberta, Galli, Luca, Paiar, Fabiola, Pasqualetti, Francesco, Erba, Paola Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627538/ https://www.ncbi.nlm.nih.gov/pubmed/34837532 http://dx.doi.org/10.1186/s13550-021-00858-8

Ejemplares similares

Radiomics-Based Inter-Lesion Relation Network to Describe [(18)F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer
por: Cavinato, Lara, et al.
Publicado: (2023)

[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019)

Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology
por: Sollini, Martina, et al.
Publicado: (2020)

Author Correction: Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance
por: Cavinato, Lara, et al.
Publicado: (2022)

Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance
por: Cavinato, Lara, et al.
Publicado: (2022)

[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
por: Pasqualetti, Francesco, et al.
Publicado: (2016)

Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series
por: Sollini, Martina, et al.
Publicado: (2016)

Alternative Nuclear Imaging Tools for Infection Imaging
por: Erba, Paola Anna, et al.
Publicado: (2022)

What to Trust, PSA or [(68)Ga]Ga-PSMA-11: Learn from Experience
por: Viglialoro, Rita, et al.
Publicado: (2021)

Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure
por: Sollini, Martina, et al.
Publicado: (2021)

Bacillus licheniformis FMCH001 Increases Water Use Efficiency via Growth Stimulation in Both Normal and Drought Conditions
por: Akhtar, Saqib Saleem, et al.
Publicado: (2020)

Mapping Tumor Heterogeneity via Local Entropy Assessment: Making Biomarkers Visible
por: Costa, Guido, et al.
Publicado: (2023)

Dual adversarial deconfounding autoencoder for joint batch-effects removal from multi-center and multi-scanner radiomics data
por: Cavinato, Lara, et al.
Publicado: (2023)

SOV_refine: A further refined definition of segment overlap score and its significance for protein structure similarity
por: Liu, Tong, et al.
Publicado: (2018)

Proposal for a definition of "Oligometastatic disease in pancreatic cancer"
por: Damanakis, Alexander I., et al.
Publicado: (2019)

Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature
por: Delishaj, Durim, et al.
Publicado: (2017)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach
por: Petrini, Iacopo, et al.
Publicado: (2022)

Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol
por: Delishaj, Durim, et al.
Publicado: (2018)

[(18)F]-Fludeoxyglucose Positron Emission Tomography/Computed Tomography with Radiomics Analysis in Patients Undergoing Aortic In-Situ Reconstruction with Cryopreserved Allografts
por: Berchiolli, Raffaella, et al.
Publicado: (2022)

Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?
por: Pasqualetti, Francesco, et al.
Publicado: (2023)

PET and PET/CT with (68)Gallium-Labeled Somatostatin Analogues in Non GEP-NETs Tumors
por: Sollini, Martina, et al.
Publicado: (2014)

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
por: Deek, Matthew P., et al.
Publicado: (2019)

Investigation of the Definition of De Novo Oligometastatic Nasopharyngeal Carcinoma: A Retrospective Study
por: Wang, Hongmei, et al.
Publicado: (2021)

The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis
por: Delishaj, Durim, et al.
Publicado: (2015)

Oligometastatic prostate cancer: definition and the role of local and systemic therapy: a narrative review
por: Mahjoub, Samy, et al.
Publicado: (2021)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Oligometastatic Breast Cancer: How to Manage It?
por: Barberi, Vittoria, et al.
Publicado: (2021)

Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series
por: Delishaj, Durim, et al.
Publicado: (2015)

Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature
por: Delishaj, Durim, et al.
Publicado: (2016)

Toward a Refined Definition of Monocyte Subsets
por: Ziegler-Heitbrock, Loems, et al.
Publicado: (2013)

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer
por: Henkenberens, Christoph, et al.
Publicado: (2021)

Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET
por: Sabbagh, Ali, et al.
Publicado: (2022)

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer
por: Mohan, Riche, et al.
Publicado: (2023)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Radiomics and liquid biopsy in oncology: the holons of systems medicine
por: Neri, Emanuele, et al.
Publicado: (2018)

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
por: Alberto, Matthew, et al.
Publicado: (2022)

Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases
por: Costa, Guido, et al.
Publicado: (2021)

[(18)F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results
por: Sollini, M., et al.
Publicado: (2017)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_57hla7ddj2nu5kmeniriirnvcm